Pharmacists need to be experts on follow-on biologics, including biosimilars, so they can provide education to health professionals about safe prescribing and use.
Roy Daniel Pollum, MD
Advertisement
Articles by Roy Daniel Pollum, MD
Advertisement
Latest Updated Articles
Biosimilars and Follow-on Biologics: A Pharmacist OpportunityNovember 16th 2016
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Scrutiny of GLP-1 Compounding Is Just Getting Started, Expert Says
2
Menin Inhibitors in AML: Frequently Asked Questions
3
FDA Approves Veligrotug-vvze as First Agent With Data in Both Active and Chronic Thyroid Eye Disease
4
From Misnomer to Meaning: A Patient-Centered Shift from PCOS to PMOS
5